Atlas Trials

AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes

Clinical trial NCT07697391 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07697391
Sponsor
The First Affiliated Hospital of Anhui Medical University
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
ObesityDiabetes Mellitus, Type 2
Start date
2026-07-20
Primary completion
2027-10-31
Enrollment
285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.